Details

Autor(en) / Beteiligte

• Carriero, Serena
• Lanza, Carolina
• Pellegrino, Giuseppe
• Ascenti, Velio
• Sattin, Caterina
• Pizzi, Caterina
• Angileri, Salvatore Alessio
• Biondetti, Pierpaolo
• Ianniello, Andrea Antonio
• Piacentino, Filippo
• Lavorato, Roberto
• Ierardi, Anna Maria
• Carrafiello, Gianpaolo

Titel

Ablative Therapies for Breast Cancer: State of Art

Ist Teil von

• Technology in Cancer Research & Treatment, 2023-01, Vol.22, p.15330338231157193-15330338231157193

Ort / Verlag

Los Angeles, CA: SAGE Publications

Erscheinungsjahr

2023

Link zum Volltext

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Breast cancer (BC) is the most frequently diagnosed malignancy among women. In the past two decades, new technologies and BC screening have led to the diagnosis of smaller and earlier-stage BC (ESBC). Therefore, percutaneous minimally invasive techniques (PMIT) were adopted to treat patients unfit for surgery, women who refuse it, or elderly patients with comorbidities that could make surgery a difficult and life-threatening treatment. The target of PMIT is small-size ESBC with the scope of obtaining similar efficacy as surgery. Minimally invasive treatments are convenient alternatives with promising effectiveness, lower morbidity, less cost, less scarring and pain, and more satisfying cosmetic results. Ablative techniques used in BC are cryoablation, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound (US), and laser ablation. The aim of our study is to discuss the current status of percutaneous management of BC, evaluate the clinical outcomes of PMIT in BC, and analyze future perspectives regarding ablation therapy in BC.